@entity239 with chronic XXXX in South Korea: a comparison of clinical and American College of Rheumatology criteria.

@entity1 @entity239 @entity627 @entity146 @entity1252 @entity158
AIM: To describe the prevalence and characteristics of @entity239 ( @entity239 ) in @entity1 with underlying @entity627 , and to compare it by three different measures. METHODS: We studied 546 @entity1 with chronic @entity627 who attended our rheumatology clinic. If @entity1 answered all of a screening questionnaire with yes, then we considered @entity1 to be having @entity158 as assessed by the @entity239 impact questionnaire (FIQ), @entity158 index (WPI), and @entity146 ( @entity146 ). A physician administered the tender point (TP) exam and clinician's judgment of @entity239 . We collected demographics, clinical and laboratory features. RESULTS: One hundred and sixty-four (30.0%) @entity1 among 546 cases had a further exam. The male-to-female count was 25  :  139. The mean age was 49.7  years, disease duration 3.7  years, TP counts 4.2, FIQ score 47.0 and WPI with @entity146 score was 11.1. We classified 17 @entity1 (10.4%) with concomitant @entity239 with @entity158 by tender point exam, 56 @entity1 (34.2%) by WPI with @entity146 , and 36 @entity1 (22.0%) by a clinician's judgment. A total of 70.6% (n  =  12) of those classified as @entity239 by 1990 American College of Rheumatology (ACR) criteria wee categorized as @entity239 by clinician's judgment, while 33.3% by clinician's judgment were classified by 1990 ACR criteria. CONCLUSIONS: We found a 10.4~34.2% prevalence of concomitant @entity239 in the @entity1 with chronic @entity158 . The 1990 ACR criteria were the most restrictive except for @entity1252 . Although The 2010 ACR criteria had a wide spectrum, it can be used for @entity239 diagnosis even in the @entity1 with underlying @entity627 .
